These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 2770373)

  • 1. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol].
    Molina JA; Calandre L; Bermejo F; Posadas F; Fernández-Ortega JD
    Med Clin (Barc); 1989 Jun; 93(1):20-2. PubMed ID: 2770373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Myoclonic and convulsive encephalopathy caused by bismuth. Usefulness of dimercaprol treatment].
    Nogué S; Mas A; Parés A; Nadal P; Bertrán A; Torra M; Bachs M; Blesa R
    Med Clin (Barc); 1985 Apr; 84(13):530-2. PubMed ID: 3999823
    [No Abstract]   [Full Text] [Related]  

  • 3. Myoclonic encephalopathy due to bismuth salts: treatment with dimercaprol and analysis of CSF transmitters.
    Molina JA; Calandre L; Bermejo F
    Acta Neurol Scand; 1989 Mar; 79(3):200-3. PubMed ID: 2566254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible encephalopathies caused by bismuth salts. 5 further cases].
    Lhermitte F; Degos CF; Signoret JL
    Nouv Presse Med; 1975 Feb; 4(6):419-20. PubMed ID: 1129094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myoclonic encephalopathy caused by bismuth].
    Gómez Jiménez J; Alvarez J; Boada Rovira M; Codina-Puiggros A
    Rev Clin Esp; 1989 Mar; 184(4):212. PubMed ID: 2740555
    [No Abstract]   [Full Text] [Related]  

  • 6. Bismuth Subgallate Toxicity in the Age of Online Supplement Use.
    Sampognaro P; Vo KT; Richie M; Blanc PD; Keenan K
    Neurologist; 2017 Nov; 22(6):237-240. PubMed ID: 29095326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Letter: Myoclonic encephalopathies caused by bismuth salts].
    Tournilhac M; Flori B; Dordain G; Roye JM
    Nouv Presse Med; 1975 Feb; 4(6):430. PubMed ID: 1129100
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth].
    Cambier J; Dairou R
    Arch Fr Mal App Dig; 1975; 64(1):5-9. PubMed ID: 1164144
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myoclonic encephalopathy caused by bismuth].
    Nogué Xarau S; Sanz Gallén P
    Rev Clin Esp; 1990 Feb; 186(3):145. PubMed ID: 2356356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Letter: Myoclonic encephalopathy and bismuth salt poisoning].
    Cambier J; Mason M; Dairou R
    Nouv Presse Med; 1974 Dec; 3(44):2662. PubMed ID: 4459861
    [No Abstract]   [Full Text] [Related]  

  • 11. [Bismuth encephalopathy in pregnant women. Apropos of a case].
    Quéreux C; Morice J; Level G; Ezes H; Wahl P
    J Gynecol Obstet Biol Reprod (Paris); 1976; 5(1):97-103. PubMed ID: 956618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoclonic encephalopathy caused by chronic bismuth abuse.
    Teepker M; Hamer HM; Knake S; Bandmann O; Oertel WH; Rosenow F
    Epileptic Disord; 2002 Dec; 4(4):229-33. PubMed ID: 12600808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy].
    Gastaut JL; Jouglard J
    Therapie; 1980; 35(3):293-6. PubMed ID: 7423414
    [No Abstract]   [Full Text] [Related]  

  • 14. [Encephalopathy caused by ingestion of bismuth salts].
    Aerts J
    Arch Belg Med Soc; 1976 Oct; 34(8):517-25. PubMed ID: 1028385
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myoclonic encephalopathies induced by bismuth salts. 6 cases observed during long-term oral treatment].
    Buge A; Rancurel G; Poisson M; Dechy H
    Nouv Presse Med; 1974 Oct; 3(36):2315-20. PubMed ID: 4218313
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications].
    Buge A; Rancurel G; Dechy H
    Rev Neurol (Paris); 1977; 133(6-7):401-15. PubMed ID: 929035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Encephalopathy during oral treatment with bismuth salts].
    Michaud PA; Regli F
    Schweiz Med Wochenschr; 1976 Apr; 106(16):550-5. PubMed ID: 988634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and electroencephalographic aspects of encephalopathy caused by insoluble bismuth salts. Apropos of 9 cases].
    Mabin D; Bedou G; Tuset MC
    Sem Hop Ther; 1976 Feb; 52(2):109-16. PubMed ID: 982067
    [No Abstract]   [Full Text] [Related]  

  • 19. [Research conducted by INSERM on myoclonic encephalopathies induced by the insoluble salts of bismuth used in gastroenterology].
    Olive G
    Therapie; 1980; 35(3):305-6. PubMed ID: 6775384
    [No Abstract]   [Full Text] [Related]  

  • 20. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts].
    Buge A; Rancurel G; Poisson M; Gazengel J; Dechy H; Fressinaud L; Emile J
    Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.